LifeStance Health Group, Inc. Long-Term Debt
LifeStance Health Group, Inc. (LFST) had Long-Term Debt of $258.99 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2026-08-06
- 2026-06-30: Long-term Debt, Excluding Current Maturities $258.99M.
- 2026-03-31: Long-term Debt, Excluding Current Maturities $262.46M.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $265.93M.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $269.39M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2026-06-30 | $258.99M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $262.46M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $265.93M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $269.39M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $272.86M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $276.32M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $279.79M 10-K · filed 2026-02-25 |
| 2024-09-30 | $279.06M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $279.46M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $279.87M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $280.29M 10-K · filed 2025-02-27 |
| 2023-09-30 | $248.37M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $248.72M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $224.76M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $225.08M 10-K · filed 2024-02-28 |
| 2022-09-30 | $212.04M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $203.36M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $177.38M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $157.42M 10-K · filed 2023-03-09 |
| 2021-09-30 | $157.45M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $157.07M 10-Q · filed 2021-08-12 |
| 2020-12-31 | $362.53M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |